Stanford Chemist
Seeking Alpha
Contact Stanford
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
Recent articles by Stanford:
Weekly Closed-End Fund Roundup: Aug 7, 2022
19 out of 23 CEF sectors positive on price and 17 out of 23 sectors positive on NAV last week. SMM will pay a Saba special distribution, funded by management. → Read More
The 'High-High-Low' Closed-End Fund Report, July 2022
Only funds with yields over 6.5%, coverage higher than 85% and trading at under a +5% premium are considered. Top lists of discount, yield, DxY and DxYxZ are given. → Read More
Weekly Closed-End Fund Roundup: VFL Tender Offer (July 24, 2022)
21 out of 23 CEF sectors positive on price and 22 out of 23 sectors positive on NAV last week. Saba scores a victory against VFL. Click here to read. → Read More
The Chemist's Quality Closed-End Fund Report, July 2022
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. → Read More
Weekly Closed-End Fund Roundup: July 17, 2022
Weekly Closed-End Fund Roundup: July 17, 2022: 21 out of 23 CEF sectors positive on price and 16 out of 23 sectors positive on NAV last week. Read more here. → Read More
GLU: Rights Offering Unexpectedly Decent (NYSE:GLU)
GLU's rights offering has concluded. A higher than expected number of rights holders subscribed. Subscribers obtained only a thin discount to the subscription price. → Read More
SMM: Discount Elimination With Proposed Merger
The board of SMM has proposed a merger with an open-ended fund which would eliminate the discount. Read more for a possible arbitrage strategy. → Read More
Weekly Closed-End Fund Roundup: July 17, 2022
21 out of 23 CEF sectors were positive on price and 16 out of 23 sectors were positive on NAV last week. Saba moves against SMM. → Read More
CLM And CRF Rights Offerings: A Success For Managers And Oversubscribers Alike
CLM and CRF's rights offerings were oversubscribed. The rights offerings were a success for managers and oversubscribers alike. Click to read more... → Read More
The 'High-High-Low' Closed-End Fund Report, June 2022
The High-High-Low CEF report screens for three attributes; High distributions, High coverage and Low premium/discount value. Check out June 2022 report here. → Read More
Weekly Closed-End Fund Roundup: June 19, 2022
0 out of 23 CEF sectors positive on price and 0 out of 23 sectors positive on NAV last week. Commodities lead while MLPs lag. → Read More
Weekly Closed-End Fund Roundup: June 5, 2022
7 out of 23 CEF sectors positive on price and 11 out of 23 sectors positive on NAV last week. CLM/CRF rights offerings expiring this week. Read more here. → Read More
The 'High-High-Low' Closed-End Fund Report, May 2022
The High-High-Low report screens for high distributions, high coverage and low premium/discount value. Click here to know more. → Read More
HIX: Rights Offering Recap And Future Prospects (NYSE:HIX)
HIX's rights offering has concluded. The subscription floor prevented more severe dilution. Read more about HIX's rights offering and future prospects. → Read More
GLU CEF: Rights Offering Quick Notes (NYSE:GLU)
GLU's rights offering is now live. Rights are discounted versus their intrinsic value, possibly arbitrage opportunity. Do not subscribe if GLU drops below $16 at expiry. → Read More
The Quality Closed-End Fund Report, May 2022
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. Top DxYxZ funds are HFRO, EHI, and IVH. → Read More
Weekly Closed-End Fund Roundup: GUT Rights Offering Results (April 24, 2022) (NYSE:GUT)
1 out of 22 CEF sectors positive on price and 1 out of 22 sectors positive on NAV last week. GUT has completed its rights offering, which was oversubscribed. → Read More
The 'High-High-Low' Closed-End Fund Report, April 2022
In this article, closed end funds with yields over 6.5%, coverage higher than 85%, and trading at under a +5% premium are considered. Check out the lists. → Read More
NHS: Rights Offering Quick Notes (NYSE:NHS)
NHS's rights offering is now live. The subscription formula has a floor of a -13% discount. Sidestepping the rights offering seems to have been the correct play once again. → Read More
Quick Notes On HIX Rights Offering (NYSE:HIX)
HIX rights offering is not going well for managers, but that's a positive for shareholders. Read what shareholders should know about HIX here. → Read More